This is a StreetInsider.com Premium Only Page

Biolase (BIOL) –

Apr 19, 2024 04:14 PM Form 8-K BIOLASE, INC For: Apr 19

Apr 11, 2024 04:55 PM Form POS AM BIOLASE, INC

Apr 4, 2024 06:01 AM Form 424B3 BIOLASE, INC

Apr 3, 2024 06:03 AM Form EFFECT BIOLASE, INC

Apr 1, 2024 03:05 AM Biolase (BIOL) PT Lowered to $4 at Ascendiant Capital

Mar 27, 2024 04:48 PM Biolase (BIOL) Announces 4.44M Share Offering by Selling Stockholders

Mar 27, 2024 04:44 PM Form S-1/A BIOLASE, INC

Mar 22, 2024 06:46 AM Biolase (BIOL) PT Lowered to $0.40 at Benchmark

Mar 22, 2024 06:02 AM Form DEFA14A BIOLASE, INC

Mar 22, 2024 06:02 AM Form DEF 14A BIOLASE, INC For: May 02

Mar 22, 2024 06:02 AM Form ARS BIOLASE, INC For: Dec 31

Mar 21, 2024 05:07 PM Form 10-K BIOLASE, INC For: Dec 31

Mar 21, 2024 04:05 PM Form 8-K BIOLASE, INC For: Mar 21

Mar 21, 2024 04:05 PM Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024

Mar 14, 2024 06:30 AM BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024

Mar 8, 2024 06:31 AM Form PRE 14A BIOLASE, INC For: May 02

Mar 5, 2024 06:17 AM Biolase (BIOL) Receives Nasdaq Non-compliance Letter

Mar 5, 2024 06:07 AM Form 8-K BIOLASE, INC For: Mar 04

Feb 27, 2024 04:16 PM Form 8-K BIOLASE, INC For: Feb 26

Feb 23, 2024 04:06 PM Form SC 13G BIOLASE, INC Filed by: S.H.N. Financial Investments Ltd.

Feb 22, 2024 06:42 AM Biolase (BIOL) Launches All-Tissue Laser System

Feb 22, 2024 06:30 AM Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry

Feb 21, 2024 04:42 PM Form SC 13G BIOLASE, INC Filed by: Lind Global Fund II LP

Feb 21, 2024 07:01 AM Form 8-K BIOLASE, INC For: Feb 20

Feb 20, 2024 06:30 AM Biolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental'

Feb 15, 2024 05:16 PM Form 8-K BIOLASE, INC For: Feb 12

Feb 15, 2024 02:45 PM BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering

Feb 15, 2024 06:05 AM Form 424B1 BIOLASE, INC

Feb 14, 2024 04:20 PM Form SC 13G BIOLASE, INC Filed by: Anson Funds Management LP

Feb 14, 2024 01:11 PM Form SC 13G/A BIOLASE, INC Filed by: LYTTON LAURENCE W

Feb 14, 2024 06:32 AM Biolase (BIOL) Granted Nasdaq Extension to Regain Compliance

Feb 14, 2024 06:30 AM BIOLASE, Inc. Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement

Feb 14, 2024 06:04 AM Form EFFECT BIOLASE, INC

Feb 13, 2024 08:04 PM Form SC 13G/A BIOLASE, INC Filed by: Lind Global Fund II LP

Feb 13, 2024 04:46 PM U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.35%

Feb 13, 2024 09:17 AM Biolase (BIOL) Announces Pricing of $7 Million Public Offering

Feb 13, 2024 09:15 AM BIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering

Feb 9, 2024 08:45 AM Form S-1/A BIOLASE, INC

Feb 7, 2024 06:11 AM Form S-1/A BIOLASE, INC

Feb 7, 2024 06:05 AM Form 8-K BIOLASE, INC For: Feb 07

Jan 31, 2024 06:07 AM Biolase (BIOL) Announces 8.8M Share and Warrant Offering

Jan 31, 2024 06:04 AM Form S-1/A BIOLASE, INC

Jan 29, 2024 05:02 PM Form 8-K BIOLASE, INC For: Jan 29

Jan 29, 2024 06:30 AM BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024

Jan 24, 2024 05:22 PM Form S-8 BIOLASE, INC

Jan 19, 2024 06:09 AM Form S-1 BIOLASE, INC

Jan 8, 2024 04:05 PM BIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023

Jan 3, 2024 04:05 PM BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD

Dec 29, 2023 04:12 PM Biolase (BIOL) Announces Resignation of Carol Gomez Summerhays from Board

Dec 29, 2023 04:06 PM Form 8-K BIOLASE, INC For: Dec 29